Evidence map›Paper›PMID 37250041›Full record

ArticleFrontiers in microbiology2023

Catabolite repression control protein antagonist, a novel player in

Elisabeth Sonnleitner, Flavia Bassani, Anastasia Cianciulli Sesso, Paul Brear, Branislav Lilic, Lovro Davidovski, Armin Resch, Ben F Luisi, Isabella Moll, Udo Bläsi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Elisabeth SonnleitnerDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, Center of Molecular Biology, Vienna Biocenter, University of Vienna, Vienna, Austria.
Flavia BassaniDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, Center of Molecular Biology, Vienna Biocenter, University of Vienna, Vienna, Austria.
Anastasia Cianciulli SessoDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, Center of Molecular Biology, Vienna Biocenter, University of Vienna, Vienna, Austria.
Paul BrearDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Branislav LilicDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, Center of Molecular Biology, Vienna Biocenter, University of Vienna, Vienna, Austria.
Lovro DavidovskiDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, Center of Molecular Biology, Vienna Biocenter, University of Vienna, Vienna, Austria.
Armin ReschDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, Center of Molecular Biology, Vienna Biocenter, University of Vienna, Vienna, Austria.
Ben F LuisiDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Isabella MollDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, Center of Molecular Biology, Vienna Biocenter, University of Vienna, Vienna, Austria.
Udo BläsiDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, Center of Molecular Biology, Vienna Biocenter, University of Vienna, Vienna, Austria.
University of Vienna · ATUniversity of Cambridge · GBVienna Biocenter · ATMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the opportunistic human pathogen

Indexed as

carbon catabolite repressioncarbon catabolite repression control proteinHfqpost-transcriptional controlPseudomonas

Identifiers

PMID37250041
PMCPMC10213629
OpenAlexW4378745841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.